By 2030, it is anticipated that the Tanzania infectious disease therapeutics market will reach a value of $72.2 Mn from $47.9 Mn in 2022, growing at a CAGR of 5.3% during 2022-2030. The Infectious Disease Therapeutics in Tanzania is dominated by a few domestic pharmaceutical companies such as Tanzania Pharmaceutical Industries, Keko Pharmaceutical and Zenufa Laboratories. The Infectious Disease Therapeutics market in Tanzania is segmented into different therapeutic areas and different diseases type. The major factors affecting the Tanzania infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Tanzania.
By 2030, it is anticipated that the Tanzania infectious disease therapeutics market will reach a value of $72.2 Mn from $47.9 Mn in 2022, growing at a CAGR of 5.3% during 2022-2030.
Tanzania is a low-income, developing country in East Africa bordering the Indian Ocean. Tanzania is particularly vulnerable to the infectious diseases listed below, according to the World Factbook. Bacterial and protozoal diarrhoea, hepatitis A, and typhoid fever are all examples of food or waterborne illnesses. In Tanzania, water-borne infectious illnesses such as schistosomiasis are frequent. Tanzania's major infectious diseases are rabies, malaria, dengue fever, and Rift Valley fever.
Tanzania has the second greatest number of cases of schistosomiasis in Sub-Saharan Africa, after only Nigeria. Malaria is the major cause of morbidity and mortality in Tanzania, affecting an estimated 93 % of the population. Tanzania's government spends 3.8% of its GDP on healthcare.
Market Growth Drivers Analysis
Tanzania has a substantial tuberculosis problem, with an estimated 70,000 new cases recorded each year. Another important health concern in Tanzania is HIV/AIDS, which is predicted to affect 1.4 Mn people by 2020. In Tanzania, the prevalence rate was 19% in 1977, but by 2012, it has risen to 51.5 % (more than 23 Mn people). In 2019, over 15 Mn Tanzanians required schistosomiasis therapy. To combat the spread of malaria, the government has launched a variety of measures, including the distribution of insecticide-treated bed nets, indoor residual spraying, and the distribution of antimalarial medications. These aspects could boost Tanzania's infectious disease therapeutics market.
Schistosomiasis is classified as a "disease of poverty" by the World Health Organization (WHO). Schistosomiasis is classified as a neglected tropical disease (NTD) because it mostly affects tropical areas "where people do not have access to safe means to dispose of human waste." Tanzania's health infrastructure is deplorable, with few resources for disease surveillance, prevention, and control. This can make it difficult to deliver infectious illness therapies effectively and limit the market potential for innovative treatments. These factors may deter new entrants into the Tanzania infectious disease therapeutics market.
The Tanzania Food and Drugs Authority (TFDA) and the Ministry of Health, Community Development, Gender, Elderly, and Children oversee the regulation and reimbursement of infectious disease medicines in Tanzania. Tanzania's national health insurance programme, which is overseen by the National Health Insurance Fund, has a considerable influence on the reimbursement process for infectious disease treatments (NHIF).
1. Report Description of the Tanzania Infectious Disease Therapeutics
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Tanzania Infectious Disease Therapeutics Executive Summary
2.1 Tanzania Infectious Disease Therapeutics – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Tanzania Infectious Disease Therapeutics
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Tanzania Infectious Disease Therapeutics Segmentation
4.1 By Mode of Treatment
4.2 By Applications
4.3 By Disease Type
4.3.1 Viral Diseases
4.3.2 Bacterial Diseases
4.3.3 Fungal Diseases
4.3.4 Parasitic Diseases
4.4 By Target Organism
4.5 By End User
4.5.1 Hospitals and Clinics
4.5.2 Ambulatory Care Centers
5. Tanzania Infectious Disease Therapeutics Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Tanzania
8.2 Regulatory Framework in Tanzania
8.3 Pricing & Reimbursement Scenario in Tanzania Infectious Disease Therapeutics
9. Factors Driving Future Growth
9.1 New Trends and Development Tanzania Infectious Disease Therapeutics
9.2 Future Opportunities
10. Strategic Recommendations
By Mode of Treatment (Revenue, USD Billion):
By Applications (Revenue, USD Billion):
By Disease Type (Revenue, USD Billion):
By Target Organism (Revenue, USD Billion):
By End User (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses